-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
February 22, 2012 - Was there a description of withdrawals and dropouts? … a) yes, with independent validation*
b) yes, eg record linkage or based on self-reports
c) no description … 4) Definition of Controls
a) no history of disease (endpoint)*
b) no description of source … provided of those lost) *
c) follow up rate < ____% (select an adequate %) and no description of those … Prognostic factors
- A clear description of a prognostic factors measured is provided.
-
effectivehealthcare.ahrq.gov/sites/default/files/use_of_handheld_mittman_respondent.pdf
January 01, 2009 - Mittman_Respondent_Ebell 2
Source:
Eisenberg
Center
Conference
Series
2009,
Translating
Information
Into
Action:
Improving
Quality
of
Care
Through
Interactive
Media,
Effective
Health
Care
Program
Web
site
(http://www.effectivehealthcare.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - primary outcomes
3
Description of secondary outcome
Analysis Description of the pre-specified … Description of the Identified Studies
Question 2. … Description of Incomplete or Discontinued Trials
Question 4. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
February 28, 2025 - If
the goal is to have this report used by people in the EMS
industry, could a simplified description … Peer Reviewer #2 Discussion/
Conclusion
Suggestion: Highlight the inclusion/exclusion criteria description … It’s covered in the chart on p.7 but the
description here is of added value (p.94, 97). … We have moved the description
of EMS population to the
Methods section (after we
introduce the eligibility … As noted above, we
have moved the description to
the Methods section.
48 Peer Reviewer #2 Discussion
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/organization-cancer-care-disposition-comments.pdf
June 20, 2023 - Further description regarding why the Integrated Framework
was chosen for evaluation would be worthwhile … Page 2,
line 47, begins a description of the Framework's development and the
literature that informed … We appreciated your
description of the
frameworks and have
incorporated that text,
as well.
23 … This a clear and comprehensive description of the
problem, the process, and the findings. … Its description of the
literature, as organized by the guiding questions, is well executed and I
have
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prevent-hai-protocol.pdf
April 16, 2024 - Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a
description … Sample Search Strategy
Embase and MEDLINE in Embase.com Syntax
Line # Description Search String
#1 … OR (oxygen NEAR/3 humidifier*) OR
(pneumatic NEAR/3 tourniquet*) OR (room* NEAR/3
8
Line # Description … *):ti OR ((cohort* OR
experimental OR observational) NEAR/2 (stud* OR
trial)):ti
9
Line # Description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
August 24, 2012 - In the results section, we include a description of
each reviewed bundled payment program,
including … a description of the bundle definition. … introduction of Case Mix Groups
(CMGs) to a description of CMGs. … In the
introduction, we added a description of cost-
based and fee-for-service payment methods and … We added a description of PROMETHEUS and
several other current programs in the results
section.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - Topic Description
Nominator: Public payer
Nomination
Summary:
The nominator questions the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - Topic Description
Nominator: Public payer
Nomination
Summary:
The nominator asks for which
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0074_03-10-2009.pdf
January 01, 2009 - Topic Description
Nominator: Individual
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
January 17, 2014 - Topic Description
Key Questions: Key Question 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
January 01, 2008 - Topic Description
Nominator: Public payer
Nomination
Summary:
The nominator suggests there
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - Topic Description
Nominator: Individual
Nomination
Summary:
The nominator questions whether
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
January 01, 2009 - Topic Description
Nominator: Individual
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0030_06-19-2008.pdf
January 01, 2008 - Topic Description
Nominator: Government agency
Nomination
Summary:
The nominator questions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
January 01, 2010 - Topic Description
Nominator: Anonymous individual
Nomination
Summary:
The nominator questions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
May 29, 2025 - Topic Description
Nominator(s): Organization
Nomination Non-invasive Tests to Diagnose Patients
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - Comment Response
Peer Reviewer
#1
Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description
of the findings to the beginning of the result … We have included a
description of and a citation for the DECIDE study in the
“Future Areas for Research … Peer Reviewer
#2
Background The Background was thorough in its description of the clinical
problem … Peer Reviewer
#4
Methods “Systematic review” may not be the most appropriate description of
this
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - However, a
description of meta-analysis goes beyond
this report. … The description of industry funding has been
removed. … The description of industry funding has been
removed. … However, there was an error in the
description of second study that has been
corrected. … However, the description of
methotrexate has been expanded.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
September 21, 2012 - in
subgroups; availability of strong a priori biological
and epidemiological evidence; detailed description … endpoints related to
outcomes, prespecification of hypotheses relating
to subgroup effects, and detailed description